Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price: 1,652.60
Bid: 1,652.60
Ask: 1,652.80
Change: 6.20 (0.38%)
Spread: 0.20 (0.01%)
Open: 1,646.40
High: 1,662.00
Low: 1,639.20
Yest. Close: 1,646.40
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 18 July Scieifitic Digital Imaging Half Year ResultsAudioboomHalf Year Year

17 Jul 19 16:07

Mereo BioPharma Names Richard Francis As New Pharmaceutical Head

(Alliance News) - Mereo BioPharma has appointed Richard Francis as the new head of pharmaceutical development, effective August 1, the biopharmaceutical company said on Tuesday.Francis was

16 Jul 19 14:46

Glaxo Reports Positive Study Results For Cancer Treatment Zejula

(Alliance News) - GlaxoSmithKline on Monday said a study of ovarian cancer treatment Zejula met its primary endpoint of a statistically significant improvement in progression free survival for of

15 Jul 19 08:43

LONDON MARKET PRE-OPEN: Glaxo Gets Positive Results From Zejula Study

(Alliance News) - Stock prices in London are seen opening slightly higher on Monday, tracking gains in Chinese equity markets despite a reported slowdown in economic growth there.In early UK news,

15 Jul 19 07:40

GlaxoSmithKline reveals positive results from 'Zejula' ovarian cancer trial

(Sharecast News) - GlaxoSmithKline announced positive results from its 'PRIMA' phase 3 randomised, double-blind, placebo-controlled study of 'Zejula' (niraparib) as a maintenance therapy in patients with first-line ovarian cancer following platinum-based chemotherapy on Monday.

15 Jul 19 07:25

TOP NEWS: GlaxoSmithKline Notes Positive Study Of HIV Two-Drug Regimen

(Alliance News) - GlaxoSmithKline PLC on Wednesday noted that the Tango study of a dolutegravir plus lamivudine two-drug regimen in HIV-1 met its primary endpoint.The phase 3 Tango study a

10 Jul 19 07:57

GSK's ViiV Trials Monthly HIV Treatment In US Clinics

(Alliance News) - GlaxoSmithKline PLC on Monday said ViiV Healthcare has commenced a trial to identify and evaluate approaches to implementing a once-monthly, injectable treatment for HIV into is

8 Jul 19 13:53

Monday broker round-up

(Sharecast News) - Computacenter: Barclays upgrades to equal weight with a target price of 1,260p.

8 Jul 19 13:18

Glaxo Notes European Commission Authorisation For HIV Drug Dovato

(Alliance News) - GlaxoSmithKline PLC on Wednesday announced the European Commission has given marketing authorisation to HIV-1 drug Dovato.Dovato, a two-drug regimen of dolutegravir and by

3 Jul 19 09:41

GlaxoSmithKline HIV treatment gets European Commission marketing approval

(Sharecast News) - GlaxoSmithKline's investee company, ViiV Healthcare, has received European Commission marketing authorisation for Dovato, which treats HIV-1 in adults and adolescents.

3 Jul 19 09:30

GlaxoSmithKline's Zejula application accepted by US Food and drug administration

(Sharecast News) - GlaxoSmithKline (GSK) confirmed on Monday Tesaro, its oncology-focused business, submitted a supplemental new drug application to the US Food & Drug Administration for its Zejula cancer treatment.

24 Jun 19 13:18

US Food & Drug Administration Accepts GSK's Application For Zejula

(Alliance News) - GlaxoSmithKline PLC on Monday said Tesaro, its oncology-focused business, submitted a supplemental new drug application to the US Food & Drug Administration for drugmaker the

24 Jun 19 12:25

Monday broker round-up

(Sharecast News) - Hammerson: Peel Hunt upgrades to add with a target price of 350p.

17 Jun 19 12:21

GSK to update on potential cancer treatment at European congress

(Sharecast News) - GlaxoSmithKline is to present studies on a potential breakthrough cancer treatment at a major conference, the drugs giant confirmed on Wednesday.

12 Jun 19 12:34

LONDON MARKET PRE-OPEN: Smiths Finds Medical CEO; Ferrexpo Improves

LONDON (Alliance News) - Stock prices in London are set to open higher Friday after a disappointing finish Thursday as the European Central Bank failed to boost sentiment.In London, FTSE Smiths a

7 Jun 19 07:36

Login to your account

Don't have an account? Click here to register.